Concepedia

Francesca Saccani

FS

Statistics

Publications

15

Citations

505

H-Index

13

Active since

2008

Affiliations

University of Parma(Current)

Istituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro

Amsterdam UMC Location Vrije Universiteit Amsterdam

University of California, Los Angeles

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Francesca Saccani is an author at University of Parma specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2008–2016

15

Publications

15

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

Daniele Cretella, Francesca Saccani, Federico Quaini et al. · Molecular Cancer · 2014 · 67 citations · Full text

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines

Maricla Galetti, Pier Giorgio Petronini, Claudia Fumarola et al. · PLoS ONE · 2015 · 64 citations · Full text

Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification

Silvia La Monica, Cristina Caffarra, Francesca Saccani et al. · PLoS ONE · 2013 · 49 citations · Full text

, , +14

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Andrea Cavazzoni, Roberta Alfieri, Daniele Cretella et al. · Molecular Cancer · 2012 · 45 citations · Full text

Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations

Mara Bonelli, Andrea Cavazzoni, Francesca Saccani et al. · Molecular Cancer Therapeutics · 2015 · 41 citations · Full text

, , +18

1–5 of 15